
WAVE Life Sciences Ltd
NASDAQ:WVE

Intrinsic Value
The intrinsic value of one
WVE
stock under the Base Case scenario is
4.72
USD.
Compared to the current market price of 8.08 USD,
WAVE Life Sciences Ltd
is
Overvalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
WAVE Life Sciences Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
WAVE Life Sciences Ltd
Balance Sheet Decomposition
WAVE Life Sciences Ltd
Current Assets | 320.4m |
Cash & Short-Term Investments | 302.1m |
Receivables | 1.4m |
Other Current Assets | 16.9m |
Non-Current Assets | 31.8m |
PP&E | 28m |
Other Non-Current Assets | 3.8m |
Free Cash Flow Analysis
WAVE Life Sciences Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
WAVE Life Sciences Ltd
Revenue
|
108.3m
USD
|
Operating Expenses
|
-218.7m
USD
|
Operating Income
|
-110.4m
USD
|
Other Expenses
|
13.4m
USD
|
Net Income
|
-97m
USD
|
WVE Profitability Score
Profitability Due Diligence
WAVE Life Sciences Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
WAVE Life Sciences Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
WVE Solvency Score
Solvency Due Diligence
WAVE Life Sciences Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Score
WAVE Life Sciences Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WVE Price Targets Summary
WAVE Life Sciences Ltd
According to Wall Street analysts, the average 1-year price target for
WVE
is 23.56 USD
with a low forecast of 14.14 USD and a high forecast of 37.8 USD.
Dividends
Current shareholder yield for WVE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
WVE
stock under the Base Case scenario is
4.72
USD.
Compared to the current market price of 8.08 USD,
WAVE Life Sciences Ltd
is
Overvalued by 42%.